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The maturation of the specific antibody response to foreign antigens (Ags)' has
been thoroughly investigated in experimental animals (1-8) . A first in vivo exposure
to Ag induces a "primary" antibody response constituted mainly ofIgM with rela-
tively low affinity for the inducing Ag. A second and any further exposure to the
same Ag evoke "secondaries" or "memory" responses that involve mainly IgG with
ahigher affinity for the Ag. Although study ofthe human antibody response to some
Ags, e.g ., tetanus toxoid (TT) and keyhole limpet hemocyanin, has been attempted
(9-13), the enormous difficulty in generating human mAbs (14, 15) has hindered
the definition of the clonal basis of such responses .
The recent progress made in the generation ofhuman mAb-producing cell lines
(14-21) and in thecharacterization of novelB cell subsets (22, 23) allowedus to inves-
tigate the human antibody response to self and exogenous Ags at the clonal level
(16-19) . In the present studies, we quantitated the circulating B cells committed to
the production of antibodies to rabies virus anddetermined theirphenotype in healthy
humans before and after multiple administrations of inactivated rabies virus vac-
cine . Moreover, usingEBV transformation and somatic cell hybridization techniques,
we constructed 10 cell hybrids secreting IgM, IgG, and IgA mAbs to the virus . We
found that in the preimmune B cell repertoire, circulating lymphocytes committed
to the production ofvirus-binding IgM, but not IgG or IgA antibodies, are present
in high number. These cells are surface CD5+ and the antibodies they produce are
polyreactive and low affinity. After vaccination with inactivated rabies virus, B lym-
phocytes producing monoreactive high affinity IgG and IgA antibodies to the virus
consistently appear in the circulating . Most ofthese cells are surface CD5- and ac-
count for >10% of the total IgG- and IgA-producing cell precursors, respectively .
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One of the IgGmAbs we generated using these cells efficiently neutralized the virus
in vitro and in vivo (Dietzschold, B ., P. Casali, Y. Ueki,M . Gore, C . E . Rupprecht,
A . L . Notkins, and H . Koprowski, manuscript submitted for publication) . Finally,
the characterization of theV gene segments of these human mAbs to rabies virus
suggested that no relationshipmay exist in the clonal origin of the (early) low affinity
IgM and the (late) high affinity IgG or IgA produced in response to the virus .
Materials and Methods
Vaccination with Inactivated Rabies Virus .
￿
The recently introduced human diploid cell vac-
cine(HDCV) against rabies virus is consistently more immunogenic and safer than the prepa-
rations previously used (24) . Preventive vaccination with HDCV is required for all labora-
tory personnel involved in handling rabies virus . Before handling the virus, four healthy
laboratory workers (three males and one female, 30-52 yr old) were vaccinated with /3-pro-
piolactone-inactivatedHDCV (PM-1503-3M strain) (Merieux Immunovax Rabies Vaccine ;
Merieux Institute, Inc ., Miami, FL) according to the recommended schedule. These sub-
jects received one intradermal dose of vaccine on days 0, 7, and 21 ; three of them received
a fourth ("booster") injection on day 142 . Venous blood (50 ml) was obtained on day -1 (be-
fore vaccination) and on days 7, 14, 28, 52, and 163 after the first injection . One subject
(B) provided 450 ml instead of 50 ml of blood on days -1 and 52 .
Preparation ofPBMC andB Lymphocytes.
￿
PBMC were separated from peripheral blood and
T lymphocytes were removed as previously decribed (25) . The remaining cells contained
N25% B lymphocytes, as defined by (BI) mAb directed to CD20 (Coulter Electronics; Inc.,
Hialeah, FL), <1% T cells, and variable proportions of monocytes, NK cells, and dendritic
cells (25) . This PBMC preparation is referred to here as B cells. CD5' and CD5- B cells
were purified from total B cells using phycoerythrin-conjugated BI mAb to CD20, FITC-
conjugated mAb to CD5', and a FAGS as described in detail (22, 23, 25) .
Titration of Total IgM, IgG, or IgA andAntibodies with Various Ag-bindingActivities.
￿
IgM, IgG,
or IgA concentrations were measured using appropriate ELISAs as described (16-18) . For
titration of IgM, IgG, and IgA to various Ags, plates (Beckman Instruments, Inc., Palo Alto,
CA) were coated with 10 tag/ml of purified human IgG Fc fragment (52,000 mol wt), ssDNA
(500,000 mol wt), 1 ug/ml of purified TT (110,000 mol wt), or 2.5 ug/ml of recombinant
human insulin (Ins) (6,000 mol wt ; a gift from Dr.W. R . Fields, Lilly Research Laboratories,
Indianapolis, IN) (18) . Antibody to rabies virus components was assayed using plates coated
with disrupted rabies virus (ERA strain, 5 jig/ml) that had been purified as described (26).
The virus glycoprotein (G ; 62,000 mol wt), ribonucleoprotein complex (RNP) (nucleoprotein,
N, 55,000 mol wt ; nonstructural protein, NS, 40,000 mol wt ; polymerase, L, 120,000 mol
wt), and membrane protein (M, 20,000 mol wt) were readily accessible to antibody on the
coated plate . Reference binding curves were constructed as described (16-18) . Specific horse-
radish peroxidase- or alkaline phosphatase-conjugated affinity-purified goat antibodies were
used to detect /A, y, H, and u, X L chains (Cappel Laboratories, Malvern, PA, and Sigma
Chemical Co., St . Louis, MO), as well as al and a2 H chains (The Binding Site Inc., San
Diego, CA) . Alkaline phosphatase-conjugated specific mouse mAbs were used to detect the
different IgG subclasses(ICN ImmunoBiologicals, Lisle, IL) . Substrate conversion was mea-
sured as absorbance at 492 or 415 nm using an automatedELISA reader (Titertek Multiskan
Plus ; Flow Laboratories, McLean, VA) .
EBV Infection and Culture of B Cells : Determination of Frequencies of Antibody-producing Cell
Precursors. Concentrated EBV` (5 x 106 transforming U/ml) was prepared as described (25) .
B cells (up to 5 x 10') were resuspended in a freshly thawed 1 .0-ml EBV aliquot and in-
cubated at 37°C for 2 h . After addition of freshFCS-RPMI (RPMI 1640medium [Biofluids,
Rockville, MD] containing 10% FCS [Gibco Laboratories, Grand Island, NY], L-glutamine
[2 mM], penicillin [50 IU/ml], and streptomycin [50 lAg/ml]), the cells were distributed in
limiting dilution microcultures (96-well round-bottomed plates ; Nunc Hazetlon, Denver, PA)
in presence of 105 syngeneic or allogeneic irradiated (1,800 rad) PBMC as feeders, as de-
scribed (16-18) . After a 4-wk culture, antibody concentration was determined in spent fluids .UEKI ET AL.
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The criteria used for determination of positiveness have been reported (18). The precursor
frequencies oftotal and rabies virus-binding IgM-, IgG-, or IgA-producing cells were calcu-
lated by analysis according to Poisson distribution (18). The precursor frequency of virus-
binding IgM-, IgG-, and IgA-producing cells were expressed as percentages of total IgM-,
IgG-, and IgA-producing cell precursors, respectively (16-18).
Human Monoclonal EBV-transformed Cell Lines and Construction of Somatic Cell Hybrids.
￿
Cell
lines producing antibodies binding rabies virus were established from EBVinfected lympho-
blasts by at leastthree sequential subculturing steps and then stabilized by fusion with F3B6
cells, an Ig nonsecretor, and HATsensitive and ouabain-resistant human-mouse hybrid (17-21).
The resulting EBVtransformed B cell hybrids were cloned at 0.5 cell/well until all progeny
microcultures produced antibody to the virus. This required in general at leastthree cloning
steps. mAbs were prepared from culture fluids as described (18).
Competitive Inhibition Studies and Kinetics ofDissociation ofHuman mAbs Binding to Solid-phase
Ag by SolubleAg. Aliquots ofPBS (0.05 ml) containing 0.057o Tween 20 and 0.117o BSA (PBS-
Tween) and 0.2-0.4 jig of mAb were mixed with aliquots of PBSTween (0.05 ml) containing
0.1% BSA and increasing amounts (0.1-200 hg) of soluble IgG Fc fragment (3.8 x 10-a to
7 .1 x 10-5 M), ssDNA (4.0 x 10-' 2 to 8.0 x 10"6 M), Ins (3 .3 x 10" to 6.6 x 10-4 M),
TT (1.8 x 10- " to 3 .6 x 10-5 M), or rabies virus components, including the G (0.003-30
jig), the RNP (0.005-50 1~g), and the M (0.002-20 1~g) protein. After an 18-h incubation
at room temperature, the mixtures were transferred into ELISA plates precoated with IgG
Fc fragment, ssDNA, Ins, TT, or rabies virus. After 1-h incubation, the mAb bound to the
solid-phase Ag was measured. The Ag-binding activity of each mAb in the presence of free
ligand was expressed as percentage of its binding activity measured under identical condi-
tions but in absence of any free ligand (100% binding). Dissociation constant (K,,, g/J,1 or
mol/liter) values were calculated as described (17, 18).
Analysis of mAb V and V,r Gene Segments.
￿
DNA probes used in this study were amplified
after insertion into the appropriate plasmids or phage and transformation of Escherichia coli
strains DH5a (Bethesda Research Laboratories, Gaithersburg, MD) or LE392 (Pharmacia
Fine Chemicals, Piscataway, NJ). The DNA inserts were prepared from plasmid DNA by
using the appropriate restriction enzymes, and these DNA fragments were labeled with deoxy-
cytidine 5'-a-[32p]triphosphate (dCTP) (sp act, 3,000 Ci/mmol; Amersham Corp., Arlington
Heights, IL) by random priming oligolabeling (27). The cDNA V segment probes used
in these studies included: 51P1 (370 bp, VI) (28), VCE-1 (310 bp, VII) (29), 56P1 (460 bp,
VIII) (29), 58P2 (405 bp, VIV) (29), 83P2 (245 bp, VV), identical to V251 (30), 15P1
(350 bp, VVI) (28), and 20Pi (222 bp, VIIIb) (28). The V probes used included: Ml-3
(320 bp, VKI) (31), M607-A (290 bp, VKII) (31), Humkv 305/Pl (3 .1 kbp, VKIII) (32), and
EVJK2 (7.0 kbp, VKIV) (33). Cellular RNA was extracted from human mAb-producing cell
lines by the guanidinium/cesium chloride method (34). Total cellular RNA (10 1~g) was slot
blotted on Gene Screen Plus membranes (New England Nuclear, Boston, MA) in 50% (vol/vol)
deionized formamide and 6% (vol/vol) formaldehyde according to the manufacturer's pro-
tocol. Blots were prehybridized for 1 h and then hybridized with different V probes at 42°C
in 50% (vol/vol) deionized formamide, 5x SSC, 5% Denhardt's solution, 25 mM NaH2PO4,
pH 6.5, 1 % SDS, and 100 lag/ml ofdenatured salmon sperm DNA. After hybridization, blots
were washed at room temperature for 30 min in 2x SSC and 0.1% SDS, and then washed
at 65°C in 0.1 x SSC and 0.1% SDS for 30 min. Autoradiography was performed using Kodak
XAR-5 film (Eastman Kodak Co., Rochester, NY).
Results
Recruitment ofPrecursors ofCells Producing IgM, IgG, and IgA Antibodies to Rabies Virus
by Inactivated Vaccine. The efficacy of the vaccination procedure was evaluated by
measuring the kinetics of the plasma virus-neutralizing activity and the titer of cir-
culating IgM, IgG, and IgA antibodies binding rabies virus after the first, as well
as after each further rabies virus vaccine administration, in four healthy human volun-
teers. Before vaccination, these subjects did not display any significant virus-neu-22
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tralizing activity, i.e., <2 IU/ml (Fig. 1). Their plasma virus-neutralizing titer, how-
ever, rose sharply as soon as 1 wk after the first vaccine injection and peaked, in
some cases to >200 IU/ml, 4 wk afterthe third injection. The sharp rise and subse-
quent steady level of the plasma virus-neutralizing activity paralleled the high con-
centrations of the plasma anti-rabies virus antibodies of the IgG, and, to a much
lesser extent, of theIgM or IgA class (Fig. 1). The increase ofplasma virus-binding
IgM was paralleled in magnitude and with similar kinetics profile by an increase
in plasma IgM binding ssDNA, TT, and Ins (not shown).
Because of the resting state of most lymphocytes in the normal B cell repertoire,
the definition of its diversity demands, as an absolute prerequisite, the useof apoly-
clonal B cell activatorcapableof inducing Ig production in each B lymphocyte clone.
We have previously shown that EBV is ideally suited forsuch a purpose in humans,
in that it induces transformation and Ig production with equal efficiency in B lym-
phocytes bearing different surface H chains, i.e., j.e, y, or ct, as well as CD5+ and
CD5- B cells (16-21, 25). To quantitate the precursors of cells producing antibodies
to rabies virus, we obtained circulating B cells from the same four subjects and at
the same times used in the experimentsdescribed above. After EBV infection, these
cells were immediately plated in limiting dilution microculture assays. After a 4-wk
culture, the frequency ofcells producingvirus-binding IgM, IgG, and IgA was de-
termined. Before any virus injection, the B cells committed to the production of
IgM-binding rabies virus constituted in some subjects up to 1.90 and 1.74% oftotal
circulating precursors of cells producing IgM and Ig, respectively (Fig. 2, A and
A'). Their percentages increased two- to threefold 1 wk after the second vaccine in-
jection and returned to the prevaccination values as early as 1 wk after the third
vaccine injection (Fig. 2, A and A').
In contrast to IgM-producing cell precursors, circulating B cells committed to
the production ofIgG and IgA to rabies virus were not detectable (<0.005% of the
total IgG- and IgA-producingcell precursors, respectively, or <0.0005% of thetotal
Ig-producing cell precursors) in any subject before the primary vaccination (Fig.
2, B, B', C, and C'). However, these lymphocytes were detected in the circulation
as early as 1 wk after the firstvaccineinjection, when B cells committed to theproduc-
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FIGURE 1.
￿
Kinetics of appearance of circulating
IgM, IgG, and IgAto rabies virus afterimmuniza-
tion with inactivated rabies virus vaccine. Rabies
virusvaccine was administered intradermallyto four
healthy subjects on days 0, 7, 21, and 142. Periph-
eral blood was obtained on days -1, 7, 14, 28, and
163afterthefirstvaccine injection. Plasma wassepa-
ratedandtested usingspecific ELISAtechniques for
rabies virus-bindingIgM(O), IgG(A), and IgA(Q)
concentration, as well as for its in vitro virus-
neutralizing titer("). Data are mean values t SD
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tion of anti-rabies virus IgG and IgA accounted for up to 6.3 and 2.5% of total
IgG- and IgA-producing cells precursors, respectively (Fig . 2, Band C), or up to
0.34 and 0.15%, respectively, of total Ig-producing cell precursors (Fig. 2, B' and
C') . Their frequency peaked 1 wk after the third vaccine injection : anti-rabies virus
IgG- andIgA-producing cell precursors constitutedup to 11.0and 12.4% ofthetotal
IgG- and IgA-producing cell precursors, respectively (Fig . 2,Band C). In each sub-
ject, thenumber ofthese cells was reduced by half or two-thirds 4wk afterthe third
vaccine injection . After the fourth injection, the frequency of B cells committed to
the production of virus-specific IgG and, to a lesser extent, IgA antibodies returned
to the peak values observed after three vaccine injections (Fig . 2, B, B', and C, C').
In general, the rise in frequencyofthe circulating anti-rabies virus IgG-producing
cell precursors preceded the increase in plasma titer of the respective antibodies,
although this relationship was less marked in the case of anti-virus IgM and IgA
antibodies, the plasma concentration ofwhichnever reached thevalues of their IgG
counterpart (compare Fig . 2, B, B', C, and C' with Fig. 1) . This together with the
results of several limiting dilution experiments (not shown) involving the culture
ofnon-EBVinfected circulating B cells from vaccinated subjects suggestedthat most
B cells "committed" to the production of IgG to rabies virus were in fact actually
producing these antibodies .
Phenotype of theB Cells Committed to the Production ofAntibodies to Rabies Virus .
￿
We
have previously shown that in the normal humanB cell repertoire a major propor-
tion (ti10-20°Jo of total B cells) of lymphocytes are committed to the production
of polyreactive, mainly IgM, antibodies, that bind a variety ofdifferent selfand ex-
ogenous Ags (18, 19, 22, 23) . These antibodies are produced by CD5+ B cells . These
lymphocytes account for the high frequency of cells committed to the production
of antibodies binding an exogenous Ag before any and after injection with the same
Ag . For example, in both subjects never exposed to TT and in those immunized
with TT, the vast majority of IgM antibodies bindingTT are produced by CD5+
B cells (22, 23) . These antibodies display a low affinity forTT and are polyreactive .
In contrast, the high affinity monoreactive IgG antibodies to TT found in T'T
vaccinated subjects are produced by CD5- B cells (18, 19, 22, 23) . To determine
whether an analogous pattern of B cell commitment to low affinity IgM and high
affinity IgG antibodies exists in response to rabies virus, we purified CD5' and
CD5- B cells from one volunteer before and after vaccination, infected these cells
with EBV, and cultured them to assess the reactivity of the antibodies produced .
Consistent with theB cell subsets segregation pattern observed in the antibody re-
sponse toTT (22), the virus-bindingIgM detected before immunization with rabies
virus and the vast majority of those detected 4wk after the third vaccine injection
were produced by CD5+ B cells ; the vast majority of the IgG antibodies detected
only after vaccination were produced by CD5- B cells (Fig. 3) .
Generation and Characterization ofHuman mAbs to Rabies Virus.
￿
To characterize the
antibodies produced in response to rabies virus, we generated, by EBVtransformation
and somatic hybridization techniques, eight mAb-producing continuous cell lines
using circulatinglymphocytes obtained from three subjects at different timesduring
immunization . Because of the overrepresentation of the B cells committed to the
production of IgM in the human B cell repertoire (18, 19, 25), when utilizing B
cells from immunized subjects, we deliberately biased the selection of rabies virus-UEKI ET AL .
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FIGURE 3 .
￿
Production ofrabies virus- bind-
ing antibodies by CD5` andCD5- B cells be-
fore and after vaccination with inactivated ra-
bies virus vaccine . CD5* and CD5 - B PBL
were purified from a subject before vaccina-
tion and 52 d after the third vaccine injection .
These cells were infected with EBV and cul-
tured in microplates at 250/well in presence
of irradiated feeders . After a 4-wk culture,
fluids were tested for antibody activity. Each
dot represents the concentration ofantibody
(expressed as absorbance at 492 nm) in the
fluid from one microculture well . Approxi-
mately 50 microculture wells were assayed in
each column .
binding antibody-producing cells in favor of those clones producingIgGor IgA over
those producing IgM . Three ofthese mAb-producingEBVtransformed hybrid cells
made IgM, four made IgG, and one made IgA . The features of these eight mAbs
were compared with those of two other IgM mAbs produced by EBVtransformed
hybrid cells generated from two of the same subjects before primary rabies virus
vaccination (Table I) . All IgMmAbs (Ab 50, 51, 52, 55, and 59)bound to theRNP
complex, in most cases, to its N component . The IgA mAb (Ab 105) and one of
the IgG (Ab 56) mAbs also bound to the RNP complex (N component) ; one of the
IgG mAbs (Ab 53) bound to theM protein ; and the remaining two IgG mAbs (Ab
53 and 57) bound to theG protein . One (Ab 57) of the two rabies virus G-binding
IgG mAbs efficiently neutralized the virus in vitro and in vivo (Dietzschold, B., P .
Casali, Y . Ueki, M. Gore, C. E. Rupprecht, A. L. Notkins, and H . Koprowski,
manuscript submitted for publication) .
To study in further detail the Ag-binding activity of these antibodies, each mAb
was tested at different concentrations for binding to solid-phase virus components,
as well as to different selfAgs (Fc fragment ofhuman IgG, ssDNA, and Ins) and
non-self Ags (TT) . The binding curves derived from the analysis of the two IgM
mAbs generated from cells obtained before immunization and one of the two IgM
mAbs generated aftercompletion ofthe immunization schedule (Table I) aredepicted
in Fig . 4, A, B, and C. These IgM mAbs were polyreactive and bound in a dose-
dependent fashion not only to rabies virus components, but also and with different
efficiency, to other Ags included in the assays . Assay of the binding activity of the
remaining two IgM mAbs, one generated after the first vaccine injection and one
generated after the fourth, gave similar results (not shown) . In contrast, the four
IgGand one IgA mAbs generatedfrom two fullyimmunized subjects were monoreac-
tive, binding in a dose-dependent fashion only to rabies virus components, and to
none of the other Ags tested . Fig . 4, D, E, andF shows the binding curves derived
from the analysis of the IgA mAb and two of the four IgG mAbs ; assay of the re-
maining two IgG mAbs gave similar results (not shown) .
The polyreactivity of the IgM as well as the monoreactivity of the IgG and IgA
mAbs were confirmedby the results of competitive inhibition experiments, inwhich26
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the binding of each mAb to solid-phase rabies virus was measured in the presence
of homologous (rabies virus) or heterologous freeAgs. Thebinding ofmAb50, mAb52,
and mAb55 to solid-phaserabies viruswas inhibited, in general inefficiently, by free
virus components as well as by different soluble heterologous Ags, including TT,
ssDNA, and Ins (Fig . 4, A', B', and C'). The converse was also true : the binding
of each IgM mAb to solid-phase Fc fragment, ssDNA, Ins, or TT was inhibited
not only by the soluble homologous Ag, but also by the soluble heterologous Ags,
as well as free rabies virus (not shown) . Competitive inhibition analysis of the two
remaining IgM mAbs provided similar results (not shown) . Unlike the binding of
polyreactive IgM mAbs, the binding of the monoreactive IgG and IgA mAbs to
solid-phase rabies virus components was inhibited very efficiently and in a dose-
dependent fashionby free rabies viruscomponents, butnot by any of the other soluble
Ags tested . These results are exemplified by the inhibition curves derived from the
analysis of mAb105, mAb57, and mAb53 (Fig . 4, D', E', and F') .
Competitive inhibition experiments involving pairs (solid and free phase) of ho-
mologous ligands allowed for the calculation of the Kd of the mAbs for the different
Ags studied . The polyreactive IgM mAbs displayed relatively high Kd values (low
affinity) for rabies virus (>10-6 g/ul) and for the other ligands tested (-10-4-10 -6
mol/liter) (Table I) . In sharp contrast, the monoreactive IgG and IgA mAbs dis-
played Kd values for rabies virus three to four orders of magnitude lower (-10-9-
10-10 g/A.1) (higher affinity) than those displayed by the polyreactive mAbs . The Kd
values of monoreactive mAbs for Ags otherthan rabies virus were too high (>5.0 x
10-3 mol/liter) to be calculated (very low affinity) .
V,, and Vr Gene Segments Usage by the mAbs to Rabies Virus.
￿
It has been reported
that polyreactive antibodies and certain rheumatoid factors may use selectedV and
VL segments (35, 36) . Probing of the slot-blotted RNA from the 10 different mAb-
producing cell lines using seven different ["P]cDNA segments, corresponding to
membersofthe six conventional V families (VI throughVVI) and to a segment
(20P1) only distantly related to theVIII family, V111b (28, 37), revealed two dis-
crete patterns ofV gene segment utilization by the polyreactive and the monoreac-
tive mAbs . RNA from all five polyreactive IgM mAb-producing cell lines hybrid-
ized with the 20P1 V cDNA probe (Table I) . In contrast, RNA from only one
(mAb 53, an IgGI) of the five monoreactive high affinity mAb-producing cell lines
hybridized with the 20P1 VcDNA (Table 1) . The hybridization of RNA from the
remaining four monoreactive high affinity mAb-producing cell lines showed that
two mAbs, an IgG2 and an IgAl, utilized members of the VIII andVVI fami-
lies, respectively (Table I) ; the othertwo mAbs, both IgG2, utilized members of the
VI and theVIV gene families. None of the mAbs utilized gene segment members
of theVII orVV gene families . Probing of the slot-blotted RNA from the seven
K+ mAb-producing cell lines using four different [s2P]DNA segments (members of
theVK I, 11, 111, and IV families) revealed a preferential utilization ofVKIII family
gene segments by the polyreactive IgM antibodies . Three of the four K+ IgM mAbs
used a gene segment member of theVKIII family. The remaining mAb utilized a
segment member of theVKII gene family. In contrast, only one ofthe three K+ IgA
and IgG mAbs utilized a segment member of theVKIII gene family ; the remaining
two utilized members of theVKI gene family (Table I) . None of the mAbs utilized
members of the VKIV gene family.UEKI ET AL .
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Discussion
Thepresent studies showed that inhumans notpreviously exposed to rabies virus,
a major proportion of circulating B lymphocytes (up to 2% of total Ig-producing
cell precursors) are committed to the production of rabies virus-binding IgM, but
not IgG or IgA (<0.0005% of total Ig-producing cell precursors) . Exposure to ra-
bies virus brings about a dramatic change in theB cell repertoire . After three vac-
cine injections, B cells committed to the production of IgG and IgA to the virus
consistently appeared in high number in the circulation, accounting for up to al-
most 1% of total Ig-producing cell precursors . In contrast, circulating B cells com-
mitted to the production of IgM capable of binding rabies virus increased only by
a factor of two to three, accounting for up to N5% of total Ig-producing cell
precursors .
The anti-rabies virus IgG and IgA antibodies displayed a discrete pattern ofAg
reactivitywhen compared with their IgMcounterparts . In fact, theIgMmAbs pro-
duced by B cells obtained either before or, even, after immunization displayed a
low affinity for rabies virus (Kd, >10-6 g/Ecl) and were polyreactive . In contrast, the
anti-rabies virus IgG and IgAmAbs produced by B cells obtained after immuniza-
tion were monoreactive and displayed a high affinity for the virus (Kd, -10 -9-
10-1° g/Al). Thus, the virus binding is but one of many Ag-binding activities ex-
pressed by the polyreactive IgM antibodies . Theselikely belong to the broader class
of antibodies definedas "natural antibodies" (17-19, 22, 38-44) . Theirpolyreactivity
and low affinity suggest that the primary B cell repertoire may be largely Ag inde-
pendent in itsgeneration, although Ag-induced IgMwith higher affinity mighthave
also participated in the rabies virus-induced response . Such antibodies, however,
wouldhave been produced by cells present only at very low frequency in the circula-
tion, and perhaps missed by our sampling procedure, i.e ., mAb generation .
The presentexperiments also showed that regardless of the specific immune status
of a subject, theB cellscommittedto the production ofpolyreactive low affinityIgM
binding to rabies virus are surface CD5+ . In contrast, in immunized subjects, those
committed to the production of monoreactive high affinity IgG are mainly surface
CD5- . This is consistent with our earlier observations suggesting that the CD5-
B cell compartment provides, or at least contains, the lymphocytes responsible for
a secondary, high affinity "mature" antibody response, as well as high affinitymemory
B cells (18, 22) .
The low affinity polyreactive IgMmAbs selected for binding to rabies virus were
restricted both in Ag reactivity and inV gene family utilization . Indeed, all of the
IgM mAbs recognized the rabies virus RNP complex, mainly its N component,
and all utilized V segment members of the same gene family, as determined by
positive hypridization of theirRNA with the 20P1 cDNA probe . The selective utili-
zation of VL gene members of the same family (V,,III) by three of four of the V,c+
IgM mAbs further underlines their genetic homogeneity. The 20P1 VH DNA seg-
ment was originally derived from a fetal liver library of expressedV segments (28)
and is utilized inunmutated configuration in a humanIgMmAbwith anti-self(Sm)
reactivity (37) . This V segment shares sequence homology with some members
of the conventional VIII family, although its allocation in the VIII family may
be questionable and might well constitute amember of a yet to be definedV sub-
family, tentatively namedVIIIb (37) .30
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The shift from low to high specificity and affinity in the antibody response to ra-
bies virus coincided with the utilization of a variety of differentV and V,, gene
segments bymost oftheparticipating cell clones. Only one(mAb53, a monoreactive
IgG2) of the five high affinity mAbs generated from the immunized subjects used
a member of theVIIIb gene family . However, unlike the polyreactive low affinity
IgM, mAb53 was specific for the viral M, notNcomponent. Thus, unless an im-
probable gene replacement mechanism (45) was operative in the response to rabies
virus, most of theB cells recruited in the late high affinity antibody response were
likely theprogenyof clones different from those committed to theproduction ofpoly-
reactive IgM antibodies . A similar shift from a V gene family restricted primary
response to a more diverse V gene segment utilization in the mature, secondary,
or tertiary response is exemplified by BALB/c mice responding to oxazolone (7) .
This contrasts with the clonal dominance ofa singleV family in both the primary
andsecondaryimmune responses, as exemplifiedby theresponse to phosphorylcho-
line in similar BALB/c mice (3), or by the response to arsonate in A/J mice (6).
Acomparable pattern of clonal dominance throughout thematuration of the human
antibody response may be found when analyzing the specific antibodies generated
by immunization with an Ag of different nature, e.g., polysaccharides .
The utilization of aVIIIb gene segment by one of the monoreactive high affinity
"secondary" antibodies maybe compatible with the hypothesis that a minor compo-
nent ofan Ag-driven "mature" antibody response to rabies virus is due to the progeny
of cells originally producing polyreactive "autoantibodies" and using selected, e.g .,
VIIIb, gene segments . These cells would undergo an Ag-driven process of clonal
expansion and somatic point mutation with simultaneous loss of the surfaceCD5
molecule ; in vitro proliferation ofnormal CD5+ B cells can be associated with loss
of the CD5 expression (23, 46) . In A/J mice, B cells producing antiarsonate anti-
bodies after active immunization are thought to be theprogeny of virgin B lympho-
cytes originally making Ig with unmutated V gene segments and endowed with
multiple "anti-self" reactivity (47). Maturation ofthe antibody response to arsonate
parallels class switch from IgM to IgG, increasing number of point mutations in
the Ig V gene segments, and loss of "anti-self" reactivity. Sequencing of the gene
segments encoding theV regionsofthepolyreactive low affinity, as well as monoreactive
high affinity, antibodies to rabies virus will help to unequivocally identify these genes
and to elucidate the possible contribution of Ag-selected somatic point mutations
to the affinity of such antibodies .
The inability to easily culture Ag-induced antibody-producing cells and to use
them to construct continuous mAb-producinghuman cell lines has been the major
impediment in the study of the human B cell function and repertoire (14, 15) . In
the present studies, by applying recently developed methods (16-21) to the analysis
oflymphocytes obtained from volunteers immunized with rabies virus, we have defined
the properties of theB cell clones recruited through the progression of the immune
response from polyreactive low affinity to monoreactive high affinity antibodies .
Moreover, we have demonstrated that human IgGmAbs ofpredetermined specificity
and high affinity and with, possibly, important biological activities (e.g ., virus neu-
tralization) can be systematically generated from theAg-primedhumanB cell reper-
toire. This approachmay be used to analyze the specific antibody response to other
foreign Ags or selfAgs in humans . It also may be used, as shown elsewhere (Dietz-UEKI ET AL.
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schold, B ., P Casali, Y. Ueki, M . Gore, C . E . Rupprecht, A . L . Notkins, and H .
Koprowski, manuscript submitted for publication), to generate human mAbs for
immediate application in vivo.
Summary
We quantitated and characterized the changes in the human B cell repertoire,
at the clonal level, before and after immunization with rabies virus . Moreover, we
generated 10 monoclonal cell lines producing IgM, IgG, and IgA antibodies to the
virus . We found that in healthy subjects, not previously exposed to the virus, nearly
2% ofthe circulatingB lymphocytes werecommitted to the production ofantibodies
that bound the virus . These B cells expressed the surface CD5 molecule . The anti-
bodies they produced were polyreactive IgM that displayed a relatively low affinity
for the virus components (Kd, 1.0-2.4 x 10-6 g/Al) . After immunization, different
anti-virus (IgG and IgA) antibody-producing cells consistently appeared in the cir-
culation and increased from <0.005% to >10% of the total B cells committed to
the production ofIgG and IgA, respectively. Most of such B cells do not express
CD5 and produce monoreactive antibodies of high affinity for rabies virus (Kd, 6.5 x
x 10-9 to 1.2 x 10-1° g/A1) . One of these IgG mAbs efficiently neutralized rabies
virus in vitro and in vivo, as detailed elsewhere (Dietzschold, B ., P Casali, Y . Ueki,
M . Gore, C . E . Rupprecht, A . L . Notkins, and H . Koprowski, manuscript sub-
mitted for publication) . Hybridization experiments using probes specific for the
different humanV gene segment families revealed that cell precursors producing
low affinity IgM binding to rabies virus utilized a restricted number ofV gene seg-
ments (i.e ., only members of the VHIIIb subfamily), whereas cell precursors
producing high affinityIgG and IgA to rabies virus utilized an assortment of different
V gene segments (i .e ., members of theV  1, VIII, VIV, and VVI families and
VIIIb subfamily) .
In conclusion, our studies show that EBV transformation in conjunction with lim-
iting dilution technology and somatic cell hybridization techniques are useful methods
for quantitating, at the B cell clonal level, the human antibody response to foreign
Agsand for generating human mAbs of predetermined specificity and high affinity.
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Receivedfor publication 8 june 1989 and in revisedform 27 July 1989.
References
1 . Milstein, C . 1986 . From antibody structure to immunological diversification ofimmune
response. Science (Wash . DC). 231:1261 .
2 . Weigert, M . 1986 . The influence of somatic mutation on the immune response . In Prog-
ress in Immunology. B . Cinader and R . G . Miller, editors . Academic Press, New York.
138-144 .
3 . Malipiero, U. V., N . S . Levy, and P . J . Gearhart, 1987 . Somatic mutation in anti-
phosphorylcholine antibodies . Immunol. Rev. 96:59 .32
￿
HUMAN MONOCLONAL ANTIBODIES TO RABIES VIRUS
4 . Rajewski, K ., I . Foster, and A . Cumano. 1987 . Evolutionary and somatic selection of
the antibody repertoire in the mouse . Science (Wash . DC) . 238:1088 .
5 . Allen, D., A . Cumano, R . Dildrop, C . Kocks, K . Rajewsky, N . Rajewsky, J . Roses, F
Sablitzky, andM . Siekevitz . 1987 . Timing, genetic requirements and functional conse-
quences of somatic hypermutation during B cell development . Immunol . Rev . 96:5 .
6 . Manser, T, L . J . Wysocki, M . N . Margolies, andM . L . Gefter. 1987 . Evolution of the
antibody variable region structure during the immune response. Immunol . Rev. 96:141 .
7 . Bereck, C ., and C . Milstein . 1988 . The dynamic nature of the antibody repertoire . Im-
munol . Rev. 105:5 .
8 . Klinman, N . R ., and P J . Linton . 1988 . The clonotype repertoire ofB cell subpopula-
tions . Adv . Immunol . 42 :1 .
9 . Thiele, C . J ., C . D. Morrow, and R . H . Stevens . 1981 . Multiple subsets of anti-tetanus
toxoid antibody-producing cells in human peripheral blood differ by size, expression of
membrane receptors, and mitogen reactivity. f Immunol . 126:1146 .
10 . Lane, H . C ., D. J . Volkman, G . Whalen, and S . Fauci . 1981 . In vitro antigen-induced,
antigen-specific antibody production in man . J . Exp. Med . 15 :1043 .
11 . Ershler, W. B ., A . L . Moore, andM . P Hacker . 1982 . Specific in vitro and in vivo anti-
body response to tetanus toxoid immunization . Clin . Exp. Immunol . 49:552 .
12 . Volkman, D. J ., S. P . Allyn, and A . S. Fauci . 1982 . Antigen-induced in vitro antibody
production in humans : tetanus toxoid specific antibody synthesis .f . Immunol . 129 :107 .
13 . Kodo, H ., R . P Gale, and A. Saxon. 1984. Antibody synthesis by bone marrow cells
in vitro following primary and booster tetanus toxoid immunization inhumans .J Clin.
Invest. 73:1377 .
14 . Carson, D. A ., and B . D. Freimark . 1986 . Human lymphocyte hybridomas and mono-
clonal antibodies. Adv . Immunol . 38:275 .
15 . James, K ., andG . T. Bell . 1987 . Human monoclonal antibody production : Current status
and future prospects . .] Immunol. Methods. 100:5 .
16 . Casali, P., G . Inghirami,M . Nakamura,T F. Davies, and A . L. Notkins . 1986 . Human
monoclonals from antigen-specific selection of B lymphocytes and transformation by EBV.
Science (Wash . DC). 234:476 .
17 . Nakamura,M ., S. E . Burastero, A . L . Notkins, and P Casali . 1988 . Human monoclonal
rheumatoid factor-like antibodies from CD5 (Leu-1)' B cells are polyreactive.j Immunol .
140:4180 .
18 . Nakamura, M ., S. E . Burastero, Y . Ueki, J . W. Larrick, A . L . Notkins, and P Casali .
1988 . Probing the normal and autoimmune B cell repertoire with EBV. Frequency of
B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's
disease and SLE . f. Immunol . 141:4165 .
19 . Casali, P ., and A . L . Notkins. 1989 . Probing the human B cell repertoire with EBV:
polyreactive antibodies and CD5' B lymphocytes . Annu. Rev . Immunol . 7 :513 .
20 . Larrick, J .W ., Y. L . Chiang, R . Sheng-Dong, G. Senyk, and P. Casali . 1988 . Genera-
tion of specific human monoclonal antibodies by in vitro expansion ofhuman B cells :
a novel recombinant DNA approach . In In Vitro Immunization in Hybridoma Tech-
nology. C . A . K . Borrebaek, editor. Elsevier Science Publishers B . V., Amsterdam . 231-246 .
21 . Casali, P., andA . L . Notkins . 1989 . The use ofEBV to probe thehumanB cell repertoire
and generate monoclonal antibodies . In Concepts in Viral Pathogenesis . III . A . L. Notkin s
and M . B . A . Oldstone, editors . Springer Verlag New York Inc ., New York . 137-145 .
22 . Casali, P., S . E . Burastero, M . Nakamura, G. Inghirami, andA . L . Notkins . 1987 . Human
lymphocytes capable of making rheumatoid factor and antibody to ssDNA belong to
the Leu-1' B cell subset . Science (Wash . DC) . 236:77 .
23 . Burastero, S . E ., and P Casali . 1989 . Characterization ofhuman CD5 (Leu-1, OKT1)'
B lymphocytes and the antibodies they produce. Contr Microbiol . Immunol. 11:231 .UEKI ET AL .
￿
3 3
24 . World Health Organization . 1984. WHO Expert Committee on Rabies, 7th Report . WHO
Monogr . Ser . 23:354 .
25 . Inghirami,G .,M . Nakamura, J . E . Balow, A . L . Notkins, and P Casali . 1988 . A model
for virus attachment : identification and quantitation of EBVbinding cells using bio-
tinylated virus in flow cytometry. f Virol. 62:2453 .
26 . Wunner, W. H ., B . Dietzschold, and T. J . Wiktor. 1985 . Antigenic structure of rhab-
doviruses . In Immunochemistry of Viruses . The Basis for Serodiagnosis and Vaccines .
M . H . V. van Regenmortel and A . R. Neurath, editors . Elsevier Science Publishers B .
V ., Amsterdam . 367-388 .
27 . Feinberg, A . P, andB . Vogelstein . 1983 . A technique for radiolabeling DNA restriction
endonucleases fragments to high specific activity. Anal. Biochem . 132:6 .
28 . Schroeder, H . W., J . L . Hillson, and R . M . Perlmutter. 1987 . Early restriction of the
human antibody repertoire. Science (Wash . DC). 238:791 .
29 . Takahashi, N ., T . Noma, andT. Honjo . 1984 . Rearranged immunoglobulin heavy chain
variable region (V ) pseudogene that deletes the second complementary determining re-
gion . Proc. Nail. Acad . Sci. USA . 81 :5194 .
30 . Shen, A., C . Humphries, P. Tucker, and F. Blattner. 1987 . Human heavy-chain variable
region gene family nonrandomly rearranged in familial chronic lymphocytic leukemia .
Proc. Nail. Acad. Sci. USA . 84:8563 .
31 . Straubinger, B ., E . Huber,W. Lorenz, E . Osterholzer,W. Pargent, M . Pech, H . D. Poh-
lenz, F. J . Zimmer, and H . G . Zachau . 1988 . The human V K locus . Characterization
ofduplicated region encoding 28 different immunoglobulin genes .f Mol. Biol. 199:23 .
32 . Chen, P. P, L . Albrandt, T. J . Kipps, V. Radoux, E T. Liu, and D . A . Carson . 1987 .
Isolation and characterization ofhuman VKIII germline genes . Implications for themo-
lecular basis of human VKIII light chain diversity. f . Immunol. 139:1727 .
33 . Stavnezer, J ., D. Kekish, D. Batter, J . Grenier, J . Balazs, E . Henderson, and B . J . M .
Zegers . 1985 . Aberran t recombination events in B cell lines derived from a k-deficient
human . Nucleic Acids Res. 13:3495 .
34 . Maniatis, T., E . F. Fritsch, and J . Sambrock . 1982 . Molecular Cloning : A Laboratory
Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 194-199 .
35 . Sanz, I ., P. Casali, J . W. Thomas, A . L . Notkins, and J . D. Capra. 1989 . Nucleotide
sequences of eight human natural autoantibodies V  region reveal apparent restricted
use of V families . J . Immunol. 142:4054 .
36 . Carson,D . A ., P P Chen, R . I . Fox,T. J . Kipps, F Jirik, R . D . Goldstein, G . Silverman,
V. Radoux, and S. Fong . 1988 . Rheumatoid factor and immune network . Annu. Rev.
Immunol. 5 :109 .
37 . Sanz, I ., H . Dang, M . Takei, N . Talal, andJ . D. Capra . 1989 . V  sequence of ahuman
anti-Sm autoantibody. Evidence that autoantibodies can be unmutated copies of germ-
line genes.J . Immunol. 142:883 .
38 . Burastero, S. E ., P . Casali, R . L . Wilder, and A . L . Notkins. 1988 . Monoreactive high
affinity and polyreactive low affinity rheumatoid factors are produced by CD5' B cells
from patients with rheumatoid arthritis . J. Exp. Med. 168:1979 .
39 . Ternynck, T, and S . Avrameas. 1986 . Murine natural monoclonal autoantibodies: a study
of their polyspecificities and their affinities . Immunol. Rev. 94:99 .
40 . Dighiero, G ., P . Lymberi, D. Holmberg, I . Lundquist, A . Coutinho, and S . Avrameas .
1985 . High frequency of natural autoantibodies in normal newborn mice . J. Immunol.
134:765 .
41 . Zouali, M ., B . D. Stollar, and R . S. Schwartz . 1985 . Origins and diversification of anti-
DNA antibodies . Immunol . Rev. 105 :137 .
42 . Holmberg, D. 1987 . High connectivity, natural antibodies preferentially use 7183 and
QPC52 V families . Eur. J . Immunol. 17:399 .34
￿
HUMAN MONOCLONAL ANTIBODIES TO RABIES VIRUS
43 . C . A . Bona. 1988. V genes encoding autoantibodies : molecular and phenotypic charac-
teristics . Annu . Rev. Immunol. 6:327 .
44 . Casali, P., and A . L . Notkins . 1989 . CD5' B lymphocytes, polyreactive antibodies and
the human B cell repertoire. Immunol. Today. 10:364.
45 . Kleinfield, R ., R. R. Hardy, D. Tarlinton, J . Dang, L . A . Herzenberg, andM . Weigert.
1986 . Recombination between an expressed human immunoglobulin heavy-chain gene
and a germline variable gene segment in a Ly-1' B-cell lymphoma. Nature (Loud.).
322:843 .
46 . Caligaris-Cappio, F., M . Riva, L. Tesio,M . Schena, G . Gaidano, and L . Bergui . 1989.
Human CD5' B lymphocytes can be induced to differentiate to CD5" B lymphocytes
with germinal center features. Blood . 73:1259 .
47 . Naparstek, Y., J . Andre-Schwartz, T. Manser, L . Wysocki, L . Breitman, B . C . Stollar,
M . Gefter, and R . S. Schwartz. 1986 . A single germ line VH gene segment of normal
A/J mice encodes autoantibodies characteristic ofsystemic lupus erythematosus.f . EXP.
Med. 164:614.